Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.82% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.26% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPLK
351
CALL
DELISTED
Splunk Inc
SPLK
| $163M | 0.04% |
1,840,300
+18,500
| +1% | +$2.03M |
|
352
PayPal
PYPL
$49.9B
| $162M | 0.04% |
2,323,310
+1,894,735
| +442% | +$164M |
|
353
CALL
Royal Caribbean
RCL
$81.8B
| $162M | 0.04% |
4,637,600
+2,022,000
| +77% | +$126M |
|
|
DOCU
354
PUT
DocuSign
DOCU
$11.1B
| $162M | 0.04% |
2,819,100
-1,311,900
| -32% | -$106M |
|
355
HubSpot
HUBS
$10.6B
| $161M | 0.04% |
535,059
+275,734
| +106% | +$101M |
|
356
PUT
CVS Health
CVS
$120B
| $161M | 0.04% |
1,736,000
-266,400
| -13% | -$26M |
|
357
CALL
Enphase Energy
ENPH
$5.47B
| $161M | 0.04% |
823,800
-72,600
| -8% | -$13.1M |
|
358
CALL
Regeneron Pharmaceuticals
REGN
$81.7B
| $160M | 0.04% |
271,200
+87,700
| +48% | +$57M |
|
359
CALL
GE Aerospace
GE
$378B
| $160M | 0.04% |
4,027,641
+578,020
| +17% | +$28M |
|
360
Roblox
RBLX
$25.5B
| $160M | 0.04% |
4,859,338
+3,814,758
| +365% | +$128M |
|
|
361
CALL
Roblox
RBLX
$25.5B
| $160M | 0.04% |
4,856,000
+2,028,200
| +72% | +$68.1M |
|
362
ConocoPhillips
COP
$151B
| $159M | 0.04% |
1,767,187
+457,005
| +35% | +$47.1M |
|
363
Workday
WDAY
$43.1B
| $158M | 0.04% |
1,133,685
+354,491
| +45% | +$64.4M |
|
364
CALL
American Express
AXP
$230B
| $158M | 0.04% |
1,139,300
-102,600
| -8% | -$16.9M |
|
365
Monster Beverage
MNST
$89.1B
| $157M | 0.04% |
6,793,404
-3,683,604
| -35% | -$80.1M |
|
|
PPL
366
PPL Corp
PPL
$26.6B
| $157M | 0.04% |
5,784,238
+5,507,499
| +1,990% | +$158M |
|
367
CALL
RH
RH
$3.39B
| $157M | 0.04% |
737,900
+11,200
| +2% | +$3.32M |
|
368
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$43.8B
| $156M | 0.04% |
1,217,300
-270,300
| -18% | -$35.4M |
|
|
PXD
369
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
| $156M | 0.04% |
698,300
+145,064
| +26% | +$36.8M |
|
370
PUT
Oracle
ORCL
$428B
| $155M | 0.04% |
2,215,600
+88,700
| +4% | +$6.49M |
|
|
371
PUT
Workday
WDAY
$43.1B
| $154M | 0.04% |
1,105,600
+206,900
| +23% | +$37.6M |
|
372
PUT
Valero Energy
VLO
$93.7B
| $154M | 0.04% |
1,449,300
+497,500
| +52% | +$58.9M |
|
373
CALL
Etsy
ETSY
$7.29B
| $154M | 0.04% |
2,100,800
+499,400
| +31% | +$45.6M |
|
374
Conagra Brands
CAG
$7.08B
| $153M | 0.04% |
4,474,450
+3,623,933
| +426% | +$123M |
|
375
Gartner
IT
$11.4B
| $153M | 0.04% |
630,831
+222,391
| +54% | +$59.2M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.